{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:57:23Z","timestamp":1772053043801,"version":"3.50.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04562-5","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:34:21Z","timestamp":1761204861000},"page":"3335-3352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Critical regulatory roles of non-coding RNAs in driving cancer sensitivity to Carmustine: a systematic review"],"prefix":"10.1007","volume":"399","author":[{"given":"Seyed Mostafa","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abouzar","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"4562_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103892","volume":"139","author":"M Aghaei","year":"2020","unstructured":"Aghaei M, KhanAhmad H, Aghaei S, Ali Nilforoushzadeh M, Mohaghegh MA, Hejazi SH (2020) The role of Bax in the apoptosis of Leishmania-infected macrophages. Microb Pathog 139:103892. https:\/\/doi.org\/10.1016\/j.micpath.2019.103892","journal-title":"Microb Pathog"},{"issue":"4","key":"4562_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, Dhanjal JK, Dewanjee S, Vallamkondu J, P\u00e9rez de la Lastra JM (2023) Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis 10(4):1367\u20131401. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.007","journal-title":"Genes Dis"},{"key":"4562_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13111536","author":"RS Angom","year":"2023","unstructured":"Angom RS, Nakka NMR, Bhattacharya S (2023) Advances in glioblastoma therapy: an update on current approaches. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci13111536","journal-title":"Brain Sci"},{"key":"4562_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione CM, Napolitano F, Esposito D, Servetto A, Belli S, Santaniello A, Scagliarini S, Crocetto F, Bianco R, Formisano L (2023) Role of FGFR3 in bladder cancer: treatment landscape and future challenges. Cancer Treat Rev 115:102530. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102530","journal-title":"Cancer Treat Rev"},{"key":"4562_CR5","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.1182\/blood-2024-204789","volume":"144","author":"Z Bahaliwah","year":"2024","unstructured":"Bahaliwah Z, Yahia AE, Alsakkaf A, Alhalouly T, Alzahrani K, Alsughayir AH, Alnoamani MS, Alshehri H, Alshehry NF, Alhumaid M, Marei M, Motabi IH, Tailor IK (2024) Outcomes of secondary CNS lymphoma with carmustine\/thiotepa conditioning and autologous stem cell transplant-a case series from single center, Saudi Arabia. Blood 144:6446. https:\/\/doi.org\/10.1182\/blood-2024-204789","journal-title":"Blood"},{"issue":"9","key":"4562_CR6","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1007\/s00210-024-03060-4","volume":"397","author":"SZ Bahojb Mahdavi","year":"2024","unstructured":"Bahojb Mahdavi SZ, Pouladi N, Amini M, Baradaran B, Najafi S, Vaghef Mehrabani S, Yari A, Ghobadi Alamdari S, Mokhtarzadeh AA (2024) Let-7a-3p overexpression increases chemosensitivity to carmustine and synergistically promotes autophagy and suppresses cell survival in U87MG glioblastoma cancer cells. Naunyn Schmiedebergs Arch Pharmacol 397(9):6903\u20136918. https:\/\/doi.org\/10.1007\/s00210-024-03060-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"4562_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12935-024-03395-1","volume":"24","author":"Y Bai","year":"2024","unstructured":"Bai Y, Zhang Z, Bi J, Tang Q, Jiang K, Yao C, Wang W (2024) MiR-181c-5p\/DERL1 pathway controls breast cancer progression mediated by TRAF6-linked K63 ubiquitination of AKT. Cancer Cell Int 24(1):204. https:\/\/doi.org\/10.1186\/s12935-024-03395-1","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4562_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"4562_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2121-14-32","volume":"14","author":"M Brentnall","year":"2013","unstructured":"Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, Boise LH (2013) Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol 14:32. https:\/\/doi.org\/10.1186\/1471-2121-14-32","journal-title":"BMC Cell Biol"},{"issue":"1","key":"4562_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Zou Z (2020) Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol 13(1):159. https:\/\/doi.org\/10.1186\/s13045-020-01000-2","journal-title":"J Hematol Oncol"},{"issue":"12","key":"4562_CR11","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.18632\/oncotarget.2005","volume":"5","author":"Y Chen","year":"2014","unstructured":"Chen Y, Chen CF, Polci R, Wei R, Riley DJ, Chen PL (2014) Increased Nek1 expression in renal cell carcinoma cells is associated with decreased sensitivity to DNA-damaging treatment. Oncotarget 5(12):4283\u20134294. https:\/\/doi.org\/10.18632\/oncotarget.2005","journal-title":"Oncotarget"},{"issue":"2","key":"4562_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hemonc.2021.05.006","volume":"15","author":"AN Chernov","year":"2022","unstructured":"Chernov AN, Alaverdian DA, Galimova ES, Renieri A, Frullanti E, Meloni I, Shamova OV (2022) The phenomenon of multidrug resistance in glioblastomas. Hematol Oncol Stem Cell Ther 15(2):1\u20137. https:\/\/doi.org\/10.1016\/j.hemonc.2021.05.006","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"4562_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12964-019-0486-4","volume":"18","author":"NJ Chew","year":"2020","unstructured":"Chew NJ, Nguyen EV, Su SP, Novy K, Chan HC, Nguyen LK, Luu J, Simpson KJ, Lee RS, Daly RJ (2020) FGFR3 signaling and function in triple negative breast cancer. Cell Commun Signal 18(1):13. https:\/\/doi.org\/10.1186\/s12964-019-0486-4","journal-title":"Cell Commun Signal"},{"key":"4562_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003193118","author":"L Chibaya","year":"2021","unstructured":"Chibaya L, Karim B, Zhang H, Jones SN (2021) Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2003193118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5660","key":"4562_CR15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1092734","volume":"303","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303(5660):1010\u20131014. https:\/\/doi.org\/10.1126\/science.1092734","journal-title":"Science"},{"issue":"1","key":"4562_CR16","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1038\/s41598-022-08091-6","volume":"12","author":"YH Chung","year":"2022","unstructured":"Chung YH, Cheng YT, Kao YH, Tsai WC, Huang GK, Chen YT, Shen YC, Tai MH, Chiang PH (2022) MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A\/\u03b2-catenin signaling. Sci Rep 12(1):6955. https:\/\/doi.org\/10.1038\/s41598-022-08091-6","journal-title":"Sci Rep"},{"issue":"2","key":"4562_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.leu.2404003","volume":"20","author":"RL Comenzo","year":"2006","unstructured":"Comenzo RL, Hassoun H, Kewalramani T, Klimek V, Dhodapkar M, Reich L, Teruya-Feldstein J, Fleisher M, Filippa D, Nimer SD (2006) Results of a phase I\/II trial adding carmustine (300 mg\/m2) to melphalan (200 mg\/m2) in multiple myeloma patients undergoing autologous stem cell transplantation. Leukemia 20(2):345\u2013349. https:\/\/doi.org\/10.1038\/sj.leu.2404003","journal-title":"Leukemia"},{"key":"4562_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.881801","volume":"12","author":"L Dai","year":"2022","unstructured":"Dai L, Tao Y, Shi Z, Liang W, Hu W, Xing Z, Zhou S, Guo X, Fu X, Wang X (2022) SOCS3 acts as an onco-immunological biomarker with value in assessing the tumor microenvironment, pathological staging, histological subtypes, therapeutic effect, and prognoses of several types of cancer. Front Oncol 12:881801. https:\/\/doi.org\/10.3389\/fonc.2022.881801","journal-title":"Front Oncol"},{"issue":"1","key":"4562_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13058-023-01683-8","volume":"25","author":"H Dai","year":"2023","unstructured":"Dai H, Xu W, Wang L, Li X, Sheng X, Zhu L, Li Y, Dong X, Zhou W, Han C, Mao Y, Yao L (2023) Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development. Breast Cancer Res 25(1):90. https:\/\/doi.org\/10.1186\/s13058-023-01683-8","journal-title":"Breast Cancer Res"},{"issue":"2","key":"4562_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24559","volume":"10","author":"HG Dailah","year":"2024","unstructured":"Dailah HG, Hommdi AA, Koriri MD, Algathlan EM, Mohan S (2024) Potential role of immunotherapy and targeted therapy in the treatment of cancer: a contemporary nursing practice. Heliyon 10(2):e24559. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24559","journal-title":"Heliyon"},{"key":"4562_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052858","author":"K Dibdiakova","year":"2024","unstructured":"Dibdiakova K, Majercikova Z, Galanda T, Richterova R, Kolarovszki B, Racay P, Hatok J (2024) Relationship between the expression of matrix metalloproteinases and their tissue inhibitors in patients with brain tumors. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25052858","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4562_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab050","volume":"3","author":"A Dono","year":"2021","unstructured":"Dono A, Ramesh AV, Wang E, Shah M, Tandon N, Ballester LY, Esquenazi Y (2021) The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Neuro-Oncol Adv 3(1):vdab050. https:\/\/doi.org\/10.1093\/noajnl\/vdab050","journal-title":"Neuro-Oncol Adv"},{"issue":"10","key":"4562_CR23","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1007\/s11033-022-07845-9","volume":"49","author":"MA Fahmy","year":"2022","unstructured":"Fahmy MA, Farghaly AA, Hassan EE, Hassan ZM, Abd-Alla HI (2022) Protective role of Codiaeum variegatum against genotoxicity induced by carmustine in somatic and germ cells of male mice. Mol Biol Rep 49(10):9543\u20139553. https:\/\/doi.org\/10.1007\/s11033-022-07845-9","journal-title":"Mol Biol Rep"},{"key":"4562_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914470","author":"GR Fajardo-Ordu\u00f1a","year":"2023","unstructured":"Fajardo-Ordu\u00f1a GR, Ledesma-Mart\u00ednez E, Agui\u00f1iga-Sanchez I, Weiss-Steider B, Santiago-Osorio E (2023) Role of SIRT1 in chemoresistant leukemia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914470","journal-title":"Int J Mol Sci"},{"key":"4562_CR25","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.2147\/ott.S222895","volume":"13","author":"J Fan","year":"2020","unstructured":"Fan J, Tian L, Huang S, Zhang J, Zhao B (2020) Derlin-1 promotes the progression of human hepatocellular carcinoma via the activation of AKT pathway. Onco Targets Ther 13:5407\u20135417. https:\/\/doi.org\/10.2147\/ott.S222895","journal-title":"Onco Targets Ther"},{"issue":"3","key":"4562_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9030324","volume":"9","author":"JP Fisher","year":"2021","unstructured":"Fisher JP, Adamson DC (2021) Current FDA-approved therapies for high-grade malignant gliomas. Biomedicines 9(3):324. https:\/\/doi.org\/10.3390\/biomedicines9030324","journal-title":"Biomedicines"},{"key":"4562_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102811","volume":"94","author":"JT Folahan","year":"2025","unstructured":"Folahan JT, Barabutis N (2025) NEK kinases in cell cycle regulation, DNA damage response, and cancer progression. Tissue Cell 94:102811. https:\/\/doi.org\/10.1016\/j.tice.2025.102811","journal-title":"Tissue Cell"},{"key":"4562_CR28","doi-asserted-by":"publisher","unstructured":"Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C, Rocco EG, Criscitiello C, Malapelle U, Invernizzi M (2020) PTEN alterations and their role in cancer management: are we making headway on precision medicine? Genes (Basel) 11(7). https:\/\/doi.org\/10.3390\/genes11070719","DOI":"10.3390\/genes11070719"},{"issue":"9","key":"4562_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrm1987","volume":"7","author":"J Gil","year":"2006","unstructured":"Gil J, Peters G (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7(9):667\u2013677. https:\/\/doi.org\/10.1038\/nrm1987","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4562_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, Teh DBL, Sethi G, Cavalieri V, Lin KH, Javidi-Sharifi NR, Toska E, Davids MS, Brown JR, Diana P, Stebbing J, Fruman DA, Kumar AP (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Mol Cancer"},{"issue":"6","key":"4562_CR31","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","volume":"109","author":"LH Goetz","year":"2018","unstructured":"Goetz LH, Schork NJ (2018) Personalized medicine: motivation, challenges, and progress. Fertil Steril 109(6):952\u2013963. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.006","journal-title":"Fertil Steril"},{"key":"4562_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020344","author":"B Gomez Solsona","year":"2022","unstructured":"Gomez Solsona B, Schmitt A, Schulze-Osthoff K, Hailfinger S (2022) The paracaspase MALT1 in cancer. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10020344","journal-title":"Biomedicines"},{"key":"4562_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114204","volume":"158","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Etemad S, Rezaei S, Ziaolhagh S, Rajabi R, Rahmanian P, Abdi S, Koohpar ZK, Rafiei R, Raei B, Ahmadi F, Salimimoghadam S, Aref AR, Zandieh MA, Entezari M, Taheriazam A, Hushmandi K (2023) Progress in targeting PTEN\/PI3K\/Akt axis in glioblastoma therapy: revisiting molecular interactions. Biomed Pharmacother 158:114204. https:\/\/doi.org\/10.1016\/j.biopha.2022.114204","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4562_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10238-025-01759-z","volume":"25","author":"M Hashemi","year":"2025","unstructured":"Hashemi M, Zali N, Ghafarzadeh Dastjerdi SZ, Pakshad B, Aliahmadi M, Sharifi N, Esfahani KS, Kohandani FS, Chamanian S, Abbasi F, Jamshidian F, Taheriazam A, Alimohammadi M, Rahimzadeh P, Farahani N, Entezari M (2025) SIRT1 as a masterful reciprocal regulator of molecular mechanisms and signaling pathways involved in tumor growth and expansion. Clin Exp Med 25(1):225. https:\/\/doi.org\/10.1007\/s10238-025-01759-z","journal-title":"Clin Exp Med"},{"issue":"5","key":"4562_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2174\/1566524022666220405125900","volume":"23","author":"E Hasheminasabgorji","year":"2023","unstructured":"Hasheminasabgorji E, Mishan MA, Tabari MAK, Bagheri A (2023) MiR-638: a promising cancer biomarker with therapeutic potential. Curr Mol Med 23(5):377\u2013389. https:\/\/doi.org\/10.2174\/1566524022666220405125900","journal-title":"Curr Mol Med"},{"issue":"1","key":"4562_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6(1):425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4562_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40364-024-00570-4","volume":"12","author":"D Hu","year":"2024","unstructured":"Hu D, Zhang Z, Luo X, Li S, Jiang J, Zhang J, Wu Z, Wang Y, Sun M, Chen X, Zhang B, Xu X, Wang S, Xu S, Wang Y, Huang W, Xia L (2024) Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy. Biomark Res 12(1):21. https:\/\/doi.org\/10.1186\/s40364-024-00570-4","journal-title":"Biomark Res"},{"issue":"4","key":"4562_CR38","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3892\/or.2014.3015","volume":"31","author":"X Huang","year":"2014","unstructured":"Huang X, Qi Q, Hua X, Li X, Zhang W, Sun H, Li S, Wang X, Li B (2014) Beclin 1, an autophagy-related gene, augments apoptosis in U87 glioblastoma cells. Oncol Rep 31(4):1761\u20131767. https:\/\/doi.org\/10.3892\/or.2014.3015","journal-title":"Oncol Rep"},{"key":"4562_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081558","author":"MF Huang","year":"2024","unstructured":"Huang MF, Wang YX, Chou YT, Lee DF (2024) Therapeutic strategies for RB1-deficient cancers: intersecting gene regulation and targeted therapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16081558","journal-title":"Cancers (Basel)"},{"issue":"20","key":"4562_CR40","doi-asserted-by":"publisher","first-page":"17873","DOI":"10.18632\/oncotarget.4286","volume":"6","author":"P Indovina","year":"2015","unstructured":"Indovina P, Pentimalli F, Casini N, Vocca I, Giordano A (2015) RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy. Oncotarget 6(20):17873\u201317890. https:\/\/doi.org\/10.18632\/oncotarget.4286","journal-title":"Oncotarget"},{"key":"4562_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116277","volume":"172","author":"Y Jegathesan","year":"2024","unstructured":"Jegathesan Y, Stephen PP, Sati I, Narayanan P, Monif M, Kamarudin MNA (2024) Micrornas in adult high-grade gliomas: mechanisms of chemotherapeutic resistance and their clinical relevance. Biomed Pharmacother 172:116277. https:\/\/doi.org\/10.1016\/j.biopha.2024.116277","journal-title":"Biomed Pharmacother"},{"issue":"33","key":"4562_CR42","doi-asserted-by":"publisher","first-page":"22785","DOI":"10.1074\/jbc.M114.587493","volume":"289","author":"S Joshi","year":"2014","unstructured":"Joshi S, Singh AR, Durden DL (2014) MDM2 regulates hypoxic hypoxia-inducible factor 1\u03b1 stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. J Biol Chem 289(33):22785\u201322797. https:\/\/doi.org\/10.1074\/jbc.M114.587493","journal-title":"J Biol Chem"},{"key":"4562_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04078-y","author":"M Khandan","year":"2025","unstructured":"Khandan M, Khazeei Tabari MA, Rahimi SM, Hassani M, Bagheri A (2025) The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04078-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4562_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105943","volume":"99","author":"A Khanizadeh","year":"2024","unstructured":"Khanizadeh A, Ghaemi A, Pourmadadi M, Javadi S, Rahdar A, Yazdian F, Ghazy E, Pandey S (2024) Advancing cancer therapy: unveiling the cutting-edge potential of carmustine nano carriers for targeted treatment. J Drug Deliv Sci Technol 99:105943","journal-title":"J Drug Deliv Sci Technol"},{"key":"4562_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6830560","volume":"2021","author":"MA Khazeei Tabari","year":"2021","unstructured":"Khazeei Tabari MA, Mishan MA, Moradi M, Khandan M, Khoshhal H, Mahrooz A, Bagheri A (2021) Noncoding RNA roles in pharmacogenomic responses to aspirin: new molecular mechanisms for an old drug. Biomed Res Int 2021:6830560. https:\/\/doi.org\/10.1155\/2021\/6830560","journal-title":"Biomed Res Int"},{"issue":"1","key":"4562_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13018-022-03048-x","volume":"17","author":"L Kong","year":"2022","unstructured":"Kong L, Ji H, Gan X, Cao S, Li Z, Jin Y (2022) Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S. J Orthop Surg Res 17(1):154. https:\/\/doi.org\/10.1186\/s13018-022-03048-x","journal-title":"J Orthop Surg Res"},{"issue":"21","key":"4562_CR47","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1038\/onc.2010.620","volume":"30","author":"HJ Kwak","year":"2011","unstructured":"Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA, Jo SH, Kim TH, Min HS, Chae JS, Choi EJ, Kim G, Shin SH, Gwak HS, Kim SK, Hong EK, Lee GK, Choi KH, Kim JH, Yoo H, Park JB, Lee SH (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30(21):2433\u20132442. https:\/\/doi.org\/10.1038\/onc.2010.620","journal-title":"Oncogene"},{"key":"4562_CR48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2147\/cmar.S157261","volume":"10","author":"YY Lee","year":"2018","unstructured":"Lee YY, Yarmishyn AA, Wang ML, Chen HY, Chiou SH, Yang YP, Lin CF, Huang PI, Chen YW, Ma HI, Chen MT (2018) Microrna-142-3p is involved in regulation of MGMT expression in glioblastoma cells. Cancer Manag Res 10:775\u2013785. https:\/\/doi.org\/10.2147\/cmar.S157261","journal-title":"Cancer Manag Res"},{"issue":"7","key":"4562_CR49","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/mc.23537","volume":"62","author":"CT Lee","year":"2023","unstructured":"Lee CT, Chu CA, Wang YM, Wang YW, Chen YL, Ho CL, Yeh YM, Lin PC, Lin BW, Chen PC, Chen SH, Chan RH, Chang C, Chow NH (2023) Dual role of sprouty2 as an inhibitor of RAS\/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer. Mol Carcinog 62(7):951\u2013962. https:\/\/doi.org\/10.1002\/mc.23537","journal-title":"Mol Carcinog"},{"key":"4562_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.692265","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Gao X (2021) LINC00883 promotes drug resistance of glioma through a microRNA-136\/NEK1-dependent mechanism. Front Oncol 11:692265. https:\/\/doi.org\/10.3389\/fonc.2021.692265","journal-title":"Front Oncol"},{"issue":"12","key":"4562_CR51","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.18632\/oncotarget.810","volume":"3","author":"H Li","year":"2012","unstructured":"Li H, Yang BB (2012) Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget 3(12):1653\u20131668. https:\/\/doi.org\/10.18632\/oncotarget.810","journal-title":"Oncotarget"},{"issue":"14","key":"4562_CR52","doi-asserted-by":"publisher","first-page":"23996","DOI":"10.18632\/oncotarget.15098","volume":"8","author":"P Li","year":"2017","unstructured":"Li P, Zhou L, Zhao T, Liu X, Zhang P, Liu Y, Zheng X, Li Q (2017a) Caspase-9: structure, mechanisms and clinical application. Oncotarget 8(14):23996\u201324008. https:\/\/doi.org\/10.18632\/oncotarget.15098","journal-title":"Oncotarget"},{"issue":"6","key":"4562_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.281","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Sun Z, Liu B, Shan Y, Zhao L, Jia L (2017b) Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. Cell Death Dis 8(6):e2892. https:\/\/doi.org\/10.1038\/cddis.2017.281","journal-title":"Cell Death Dis"},{"issue":"1","key":"4562_CR54","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1186\/s12885-019-6161-8","volume":"19","author":"L Li","year":"2019","unstructured":"Li L, Zhang S, Li H, Chou H (2019) Fgfr3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR. BMC Cancer 19(1):963. https:\/\/doi.org\/10.1186\/s12885-019-6161-8","journal-title":"BMC Cancer"},{"key":"4562_CR55","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"issue":"4","key":"4562_CR56","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317695945","volume":"39","author":"E L\u00f3pez-Urrutia","year":"2017","unstructured":"L\u00f3pez-Urrutia E, Coronel-Hern\u00e1ndez J, Garc\u00eda-Castillo V, Contreras-Romero C, Mart\u00ednez-Gutierrez A, Estrada-Galicia D, Terrazas LI, L\u00f3pez-Camarillo C, Maldonado-Mart\u00ednez H, Jacobo-Herrera N, P\u00e9rez-Plasencia C (2017) Mir-26a downregulates retinoblastoma in colorectal cancer. Tumour Biol 39(4):1010428317695945. https:\/\/doi.org\/10.1177\/1010428317695945","journal-title":"Tumour Biol"},{"key":"4562_CR57","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2147\/ott.S85677","volume":"8","author":"Y Luan","year":"2015","unstructured":"Luan Y, Zhang S, Zuo L, Zhou L (2015) Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3. Onco Targets Ther 8:3391\u20133400. https:\/\/doi.org\/10.2147\/ott.S85677","journal-title":"Onco Targets Ther"},{"issue":"1","key":"4562_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41419-022-05506-0","volume":"14","author":"M Luo","year":"2023","unstructured":"Luo M, Deng X, Chen Z, Hu Y (2023) Circular RNA circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer. Cell Death Dis 14(1):10. https:\/\/doi.org\/10.1038\/s41419-022-05506-0","journal-title":"Cell Death Dis"},{"key":"4562_CR59","doi-asserted-by":"publisher","unstructured":"Luongo F, Colonna F, Calap\u00e0 F, Vitale S, Fiori ME, De Maria R (2019) PTEN tumor-suppressor: the dam of stemness in cancer. Cancers (Basel) 11(8). https:\/\/doi.org\/10.3390\/cancers11081076","DOI":"10.3390\/cancers11081076"},{"key":"4562_CR60","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.biopha.2018.02.118","volume":"101","author":"Y Ma","year":"2018","unstructured":"Ma Y, Deng F, Li P, Chen G, Tao Y, Wang H (2018) The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells. Biomed Pharmacother 101:648\u2013655. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.118","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4562_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60144-2","volume":"16","author":"J Ma","year":"2025","unstructured":"Ma J, Zhao J, Zhang C, Tan J, Cheng A, Niu Z, Lin Z, Pan G, Chen C, Ding Y, Zhong M, Zhuang Y, Xiong Y, Zhou H, Zhou S, Xu M, Ye W, Li F, Song Y, Wang Z, Hong X (2025) Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy. Nat Commun 16(1):5006. https:\/\/doi.org\/10.1038\/s41467-025-60144-2","journal-title":"Nat Commun"},{"key":"4562_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063313","author":"AG Magar","year":"2024","unstructured":"Magar AG, Morya VK, Kwak MK, Oh JU, Noh KC (2024) A molecular perspective on HIF-1\u03b1 and angiogenic stimulator networks and their role in solid tumors: an update. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25063313","journal-title":"Int J Mol Sci"},{"key":"4562_CR63","doi-asserted-by":"publisher","unstructured":"Maietta I, Viscusi E, Laudati S, Iannaci G, D'Antonio A, Melillo RM, Motti ML, De Falco V (2024) Targeting the p90RSK\/MDM2\/p53 pathway is effective in blocking tumors with oncogenic up-regulation of the MAPK pathway such as melanoma and lung cancer. Cells 13(18). https:\/\/doi.org\/10.3390\/cells13181546","DOI":"10.3390\/cells13181546"},{"issue":"1","key":"4562_CR64","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1038\/s41598-017-05325-w","volume":"7","author":"TD Melo-Hanchuk","year":"2017","unstructured":"Melo-Hanchuk TD, Slepicka PF, Meirelles GV, Basei FL, Lovato DV, Granato DC, Pauletti BA, Domingues RR, Leme AFP, Pelegrini AL, Lenz G, Knapp S, Elkins JM, Kobarg J (2017) NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin. Sci Rep 7(1):5445. https:\/\/doi.org\/10.1038\/s41598-017-05325-w","journal-title":"Sci Rep"},{"key":"4562_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173325","volume":"882","author":"MA Mishan","year":"2020","unstructured":"Mishan MA, Khazeei Tabari MA, Zargari M, Bagheri A (2020) Micrornas in the anticancer effects of celecoxib: a systematic review. Eur J Pharmacol 882:173325. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173325","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"4562_CR66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/cej.0000000000000645","volume":"30","author":"MA Mishan","year":"2021","unstructured":"Mishan MA, Khazeei Tabari MA, Mahrooz A, Bagheri A (2021) Role of micrornas in the anticancer effects of the flavonoid luteolin: a systematic review. Eur J Cancer Prev 30(5):413\u2013421. https:\/\/doi.org\/10.1097\/cej.0000000000000645","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"4562_CR67","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ncrna.2021.12.001","volume":"6","author":"P Mondal","year":"2021","unstructured":"Mondal P, Meeran SM (2021) Micrornas in cancer chemoresistance: the sword and the shield. Noncoding RNA Res 6(4):200\u2013210. https:\/\/doi.org\/10.1016\/j.ncrna.2021.12.001","journal-title":"Noncoding RNA Res"},{"key":"4562_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174363","author":"CM Neophytou","year":"2021","unstructured":"Neophytou CM, Trougakos IP, Erin N, Papageorgis P (2021) Apoptosis deregulation and the development of cancer multi-drug resistance. Cancers. https:\/\/doi.org\/10.3390\/cancers13174363","journal-title":"Cancers"},{"issue":"1","key":"4562_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3803\/EnM.2024.101","volume":"39","author":"EC Nijenhuis-Noort","year":"2024","unstructured":"Nijenhuis-Noort EC, Berk KA, Neggers S, Lely AJV (2024) The fascinating interplay between growth hormone, insulin-like growth factor-1, and insulin. Endocrinol Metab (Seoul) 39(1):83\u201389. https:\/\/doi.org\/10.3803\/EnM.2024.101","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"4562_CR70","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbcan.2017.01.004","volume":"1868","author":"T Nikolova","year":"2017","unstructured":"Nikolova T, Roos WP, Kr\u00e4mer OH, Strik HM, Kaina B (2017) Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling. Biochim Biophys Acta Rev Cancer 1868(1):29\u201339. https:\/\/doi.org\/10.1016\/j.bbcan.2017.01.004","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"4562_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1476-4431.2008.00363.x","volume":"18","author":"MA O'Brien","year":"2008","unstructured":"O\u2019Brien MA, Kirby R (2008) Apoptosis: a review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease. J Vet Emerg Crit Care 18(6):572\u2013585. https:\/\/doi.org\/10.1111\/j.1476-4431.2008.00363.x","journal-title":"J Vet Emerg Crit Care"},{"issue":"4","key":"4562_CR72","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.sjbs.2021.11.056","volume":"29","author":"C Oka","year":"2022","unstructured":"Oka C, Saleh R, Bessho Y, Reza HM (2022) Interplay between HTRA1 and classical signalling pathways in organogenesis and diseases. Saudi J Biol Sci 29(4):1919\u20131927. https:\/\/doi.org\/10.1016\/j.sjbs.2021.11.056","journal-title":"Saudi J Biol Sci"},{"key":"4562_CR73","doi-asserted-by":"publisher","unstructured":"Picca A, Sansone G, Santonocito OS, Mazzanti CM, Sanson M, Di Stefano AL (2023) Diffuse gliomas with FGFR3-TACC3 fusions: oncogenic mechanisms, hallmarks, and therapeutic perspectives. Cancers (Basel) 15(23). https:\/\/doi.org\/10.3390\/cancers15235555","DOI":"10.3390\/cancers15235555"},{"key":"4562_CR74","doi-asserted-by":"publisher","first-page":"1368606","DOI":"10.3389\/fonc.2024.1368606","volume":"14","author":"J P\u00f6hlmann","year":"2024","unstructured":"P\u00f6hlmann J, Weller M, Marcellusi A, Grabe-Heyne K, Krott-Coi L, Rabar S, Pollock RF (2024) High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma. Front Oncol 14:1368606. https:\/\/doi.org\/10.3389\/fonc.2024.1368606","journal-title":"Front Oncol"},{"key":"4562_CR75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcell.2018.00013","volume":"6","author":"N Popgeorgiev","year":"2018","unstructured":"Popgeorgiev N, Jabbour L, Gillet G (2018) Subcellular localization and dynamics of the Bcl-2 family of proteins. Front Cell Dev Biol 6:13. https:\/\/doi.org\/10.3389\/fcell.2018.00013","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"4562_CR76","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2012.07.025","volume":"525","author":"Y Qu","year":"2012","unstructured":"Qu Y, Zhang J, Wu S, Li B, Liu S, Cheng J (2012) SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines. Neurosci Lett 525(2):168\u2013172. https:\/\/doi.org\/10.1016\/j.neulet.2012.07.025","journal-title":"Neurosci Lett"},{"key":"4562_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102650","author":"M Ratti","year":"2023","unstructured":"Ratti M, Orlandi E, Hahne JC, Vecchia S, Citterio C, Anselmi E, Toscani I, Ghidini M (2023) Targeting FGFR pathways in gastrointestinal cancers: new frontiers of treatment. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11102650","journal-title":"Biomedicines"},{"key":"4562_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121584","volume":"617","author":"LS Reinhardt","year":"2022","unstructured":"Reinhardt LS, Mor\u00e1s AM, Henn JG, Arantes PR, Ferro MB, Braganhol E, de Souza PO, de Oliveira Merib J, Borges GR, Dalanhol CS, de Barros Dias MCH, Nugent M, Moura DJ (2022) Nek1-inhibitor and temozolomide-loaded microfibers as a co-therapy strategy for glioblastoma treatment. Int J Pharm 617:121584. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121584","journal-title":"Int J Pharm"},{"key":"4562_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173483","volume":"888","author":"T Rezaei","year":"2020","unstructured":"Rezaei T, Hejazi M, Mansoori B, Mohammadi A, Amini M, Mosafer J, Rezaei S, Mokhtarzadeh A, Baradaran B (2020) Microrna-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis. Eur J Pharmacol 888:173483. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173483","journal-title":"Eur J Pharmacol"},{"key":"4562_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.884158","volume":"13","author":"L Ricciardi","year":"2022","unstructured":"Ricciardi L, Manini I, Cesselli D, Trungu S, Piazza A, Mangraviti A, Miscusi M, Raco A, Ius T (2022) Carmustine wafers implantation in patients with newly diagnosed high grade glioma: is it still an option? Front Neurol 13:884158. https:\/\/doi.org\/10.3389\/fneur.2022.884158","journal-title":"Front Neurol"},{"issue":"6","key":"4562_CR81","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/0008-5472.Can-18-4099","volume":"80","author":"M Sato","year":"2020","unstructured":"Sato M, Matsumoto M, Saiki Y, Alam M, Nishizawa H, Rokugo M, Brydun A, Yamada S, Kaneko MK, Funayama R, Ito M, Kato Y, Nakayama K, Unno M, Igarashi K (2020) BACH1 promotes pancreatic cancer metastasis by repressing epithelial genes and enhancing epithelial-mesenchymal transition. Cancer Res 80(6):1279\u20131292. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-4099","journal-title":"Cancer Res"},{"issue":"11","key":"4562_CR82","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1002\/cam4.871","volume":"5","author":"T Shanmugalingam","year":"2016","unstructured":"Shanmugalingam T, Bosco C, Ridley AJ, Van Hemelrijck M (2016) Is there a role for IGF-1 in the development of second primary cancers? Cancer Med 5(11):3353\u20133367. https:\/\/doi.org\/10.1002\/cam4.871","journal-title":"Cancer Med"},{"key":"4562_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/biom15010035","author":"A Shoari","year":"2024","unstructured":"Shoari A, Ashja Ardalan A, Dimesa AM, Coban MA (2024) Targeting invasion: the role of MMP-2 and MMP-9 inhibition in colorectal cancer therapy. Biomolecules. https:\/\/doi.org\/10.3390\/biom15010035","journal-title":"Biomolecules"},{"issue":"1","key":"4562_CR84","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/neuros\/nyy214","volume":"85","author":"C Sippl","year":"2019","unstructured":"Sippl C, Ketter R, Bohr L, Kim YJ, List M, Oertel J, Urbschat S (2019a) Mirna-181d expression significantly affects treatment responses to carmustine wafer implantation. Neurosurgery 85(1):147\u2013155. https:\/\/doi.org\/10.1093\/neuros\/nyy214","journal-title":"Neurosurgery"},{"issue":"11","key":"4562_CR85","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00701-019-04051-8","volume":"161","author":"C Sippl","year":"2019","unstructured":"Sippl C, Ketter R, Braun L, Teping F, Schoeneberger L, Kim YJ, List M, Nakhoda A, Wemmert S, Oertel J, Urbschat S (2019b) Mirna-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme. Acta Neurochir (Wien) 161(11):2299\u20132309. https:\/\/doi.org\/10.1007\/s00701-019-04051-8","journal-title":"Acta Neurochir (Wien)"},{"key":"4562_CR86","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1016\/j.wneu.2021.12.053","volume":"159","author":"C Sippl","year":"2022","unstructured":"Sippl C, Quiring A, Teping F, Schulz-Schaeffer W, Urbschat S, Ketter R, Oertel J (2022) MiRNA-181d expression correlates in tumor versus plasma of glioblastoma patients-the base of a preoperative stratification tool for local carmustine wafer use. World Neurosurg 159:e324\u2013e333. https:\/\/doi.org\/10.1016\/j.wneu.2021.12.053","journal-title":"World Neurosurg"},{"key":"4562_CR87","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/bs.apha.2024.04.002","volume":"100","author":"CK S\u00f8gaard","year":"2024","unstructured":"S\u00f8gaard CK, Otterlei M (2024) Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy. Adv Pharmacol 100:209\u2013246. https:\/\/doi.org\/10.1016\/bs.apha.2024.04.002","journal-title":"Adv Pharmacol"},{"issue":"1","key":"4562_CR88","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gendis.2022.05.006","volume":"10","author":"Y Song","year":"2023","unstructured":"Song Y, Bi Z, Liu Y, Qin F, Wei Y, Wei X (2023) Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: current status in clinical trials. Genes Dis 10(1):76\u201388. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.006","journal-title":"Genes Dis"},{"issue":"12","key":"4562_CR89","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/stmcls\/sxae060","volume":"42","author":"SJ Sonnentag","year":"2024","unstructured":"Sonnentag SJ, Ibrahim NSM, Orian-Rousseau V (2024) CD44: a stemness driver, regulator, and marker-all in one? Stem Cells 42(12):1031\u20131039. https:\/\/doi.org\/10.1093\/stmcls\/sxae060","journal-title":"Stem Cells"},{"issue":"4","key":"4562_CR90","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1021\/bi9518205","volume":"35","author":"KS Srivenugopal","year":"1996","unstructured":"Srivenugopal KS, Yuan XH, Friedman HS, Ali-Osman F (1996) Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochemistry 35(4):1328\u20131334. https:\/\/doi.org\/10.1021\/bi9518205","journal-title":"Biochemistry"},{"key":"4562_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10082030","author":"M Szylberg","year":"2022","unstructured":"Szylberg M, Sokal P, \u015aledzi\u0144ska P, Bebyn M, Krajewski S, Szylberg \u0141, Szylberg A, Szylberg T, Krystkiewicz K, Birski M, Harat M, W\u0142odarski R, Furtak J (2022) MGMT promoter methylation as a prognostic factor in primary glioblastoma: a single-institution observational study. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10082030","journal-title":"Biomedicines"},{"issue":"Pt 2","key":"4562_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116588","volume":"230","author":"Q Tang","year":"2024","unstructured":"Tang Q, Ren T, Bai P, Wang X, Zhao L, Zhong R, Sun G (2024) Novel strategies to overcome chemoresistance in human glioblastoma. Biochem Pharmacol 230(Pt 2):116588. https:\/\/doi.org\/10.1016\/j.bcp.2024.116588","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"4562_CR93","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M (2018) NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18(5):309\u2013324. https:\/\/doi.org\/10.1038\/nri.2017.142","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4562_CR94","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.gendis.2014.09.005","volume":"1","author":"CM Teven","year":"2014","unstructured":"Teven CM, Farina EM, Rivas J, Reid RR (2014) Fibroblast growth factor (FGF) signaling in development and skeletal diseases. Genes Dis 1(2):199\u2013213. https:\/\/doi.org\/10.1016\/j.gendis.2014.09.005","journal-title":"Genes Dis"},{"key":"4562_CR95","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5567","author":"Y Tian","year":"2023","unstructured":"Tian Y, Lei Y, Wang Y, Lai J, Wang J, Xia F (2023) Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (review). Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2023.5567","journal-title":"Int J Oncol"},{"key":"4562_CR96","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3249766","author":"BXJ Tune","year":"2022","unstructured":"Tune BXJ, Sim MS, Poh CL, Guad RM, Woon CK, Hazarika I, Das A, Gopinath SCB, Rajan M, Sekar M, Subramaniyan V, Fuloria NK, Fuloria S, Batumalaie K, Wu YS (2022) Matrix metalloproteinases in chemoresistance: regulatory roles, molecular interactions, and potential inhibitors. J Oncol. https:\/\/doi.org\/10.1155\/2022\/3249766","journal-title":"J Oncol"},{"issue":"1","key":"4562_CR97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","volume":"10","author":"M Vogler","year":"2025","unstructured":"Vogler M, Braun Y, Smith VM, Westhoff MA, Pereira RS, Pieper NM, Anders M, Callens M, Vervliet T, Abbas M, Macip S, Schmid R, Bultynck G, Dyer MJ (2025) The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Ther 10(1):91. https:\/\/doi.org\/10.1038\/s41392-025-02176-0","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"4562_CR98","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.26355\/eurrev_201711_13819","volume":"21","author":"GB Wang","year":"2017","unstructured":"Wang GB, Liu JH, Hu J, Xue K (2017) MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression. Eur Rev Med Pharmacol Sci 21(22):5065\u20135071. https:\/\/doi.org\/10.26355\/eurrev_201711_13819","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"4562_CR99","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20517\/cdr.2019.10","volume":"2","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang H, Chen X (2019) Drug resistance and combating drug resistance in cancer. Cancer Drug Resist 2(2):141\u2013160. https:\/\/doi.org\/10.20517\/cdr.2019.10","journal-title":"Cancer Drug Resist"},{"key":"4562_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100743","volume":"54","author":"JQ Wang","year":"2021","unstructured":"Wang JQ, Yang Y, Cai CY, Teng QX, Cui Q, Lin J, Assaraf YG, Chen ZS (2021) Multidrug resistance proteins (MRPs): structure, function and the overcoming of cancer multidrug resistance. Drug Resist Updat 54:100743. https:\/\/doi.org\/10.1016\/j.drup.2021.100743","journal-title":"Drug Resist Updat"},{"issue":"1","key":"4562_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00417-5","volume":"7","author":"Z Wang","year":"2023","unstructured":"Wang Z, Muthusamy V, Petrylak DP, Anderson KS (2023) Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR\/HDAC targeted therapy. NPJ Precis Oncol 7(1):70. https:\/\/doi.org\/10.1038\/s41698-023-00417-5","journal-title":"NPJ Precis Oncol"},{"key":"4562_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117458","volume":"180","author":"W Wang","year":"2024","unstructured":"Wang W, Liu Y, Wu J (2024) The roles of lncRNAs in the development of drug resistance of oral cancers. Biomed Pharmacother 180:117458. https:\/\/doi.org\/10.1016\/j.biopha.2024.117458","journal-title":"Biomed Pharmacother"},{"key":"4562_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1226639","volume":"11","author":"L Wei","year":"2023","unstructured":"Wei L, Sun J, Wang X, Huang Y, Huang L, Han L, Zheng Y, Xu Y, Zhang N, Yang M (2023) Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer. Front Cell Dev Biol 11:1226639. https:\/\/doi.org\/10.3389\/fcell.2023.1226639","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"4562_CR104","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","volume":"5","author":"M Westphal","year":"2003","unstructured":"Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, J\u00e4\u00e4skel\u00e4inen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5(2):79\u201388. https:\/\/doi.org\/10.1093\/neuonc\/5.2.79","journal-title":"Neuro Oncol"},{"key":"4562_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413691","author":"M Wolosowicz","year":"2024","unstructured":"Wolosowicz M, Prokopiuk S, Kaminski TW (2024) The complex role of matrix metalloproteinase-2 (MMP-2) in health and disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252413691","journal-title":"Int J Mol Sci"},{"key":"4562_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111603","volume":"139","author":"L Wu","year":"2021","unstructured":"Wu L, Li X, Li Z, Cheng Y, Wu F, Lv C, Zhang W, Tang W (2021) HtrA serine proteases in cancers: a target of interest for cancer therapy. Biomed Pharmacother 139:111603. https:\/\/doi.org\/10.1016\/j.biopha.2021.111603","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"4562_CR107","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.Cir-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia Y, Shen S, Verma IM (2014) NF-\u03baB, an active player in human cancers. Cancer Immunol Res 2(9):823\u2013830. https:\/\/doi.org\/10.1158\/2326-6066.Cir-14-0112","journal-title":"Cancer Immunol Res"},{"key":"4562_CR108","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fneur.2020.01036","volume":"11","author":"ZZ Xiao","year":"2020","unstructured":"Xiao ZZ, Wang ZF, Lan T, Huang WH, Zhao YH, Ma C, Li ZQ (2020) Carmustine as a supplementary therapeutic option for glioblastoma: a systematic review and meta-analysis. Front Neurol 11:1036. https:\/\/doi.org\/10.3389\/fneur.2020.01036","journal-title":"Front Neurol"},{"issue":"5","key":"4562_CR109","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/neup.12129","volume":"34","author":"Q Xie","year":"2014","unstructured":"Xie Q, Yan Y, Huang Z, Zhong X, Huang L (2014) Microrna-221 targeting PI3-K\/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma. Neuropathology 34(5):455\u2013464. https:\/\/doi.org\/10.1111\/neup.12129","journal-title":"Neuropathology"},{"issue":"1","key":"4562_CR110","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10528-022-10246-z","volume":"61","author":"Y Xu","year":"2023","unstructured":"Xu Y (2023) MiRNA-21-5p accelerates EMT and inhibits apoptosis of laryngeal carcinoma via inhibiting KLF6 expression. Biochem Genet 61(1):101\u2013115. https:\/\/doi.org\/10.1007\/s10528-022-10246-z","journal-title":"Biochem Genet"},{"key":"4562_CR111","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3389\/fimmu.2018.02334","volume":"9","author":"X Ye","year":"2018","unstructured":"Ye X, Zhou XJ, Zhang H (2018) Exploring the role of autophagy-related gene 5 (ATG5) yields important insights into autophagy in autoimmune\/autoinflammatory diseases. Front Immunol 9:2334. https:\/\/doi.org\/10.3389\/fimmu.2018.02334","journal-title":"Front Immunol"},{"issue":"2","key":"4562_CR112","doi-asserted-by":"publisher","first-page":"199","DOI":"10.22074\/cellj.2021.7038","volume":"23","author":"QH Yin","year":"2021","unstructured":"Yin QH, Zhou Y, Li ZHY (2021) miR-373 suppresses cell proliferation and apoptosis via regulation of SIRT1\/PGC-1\u03b1\/NRF2 axis in pancreatic cancer. Cell J 23(2):199\u2013210. https:\/\/doi.org\/10.22074\/cellj.2021.7038","journal-title":"Cell J"},{"issue":"1","key":"4562_CR113","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gene.2016.09.010","volume":"594","author":"N Yu","year":"2016","unstructured":"Yu N, Yang Y, Li X, Zhang M, Huang J, Wang X, Long X (2016) Mir-26a inhibits proliferation and migration of HaCaT keratinocytes through regulating PTEN expression. Gene 594(1):117\u2013124. https:\/\/doi.org\/10.1016\/j.gene.2016.09.010","journal-title":"Gene"},{"key":"4562_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01547","volume":"9","author":"W Yu","year":"2019","unstructured":"Yu W, Zhang L, Wei Q, Shao A (2019) O(6)-methylguanine-DNA methyltransferase (MGMT): challenges and new opportunities in glioma chemotherapy. Front Oncol 9:1547. https:\/\/doi.org\/10.3389\/fonc.2019.01547","journal-title":"Front Oncol"},{"issue":"1","key":"4562_CR115","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00210-024-03287-1","volume":"398","author":"SJ Zaer","year":"2025","unstructured":"Zaer SJ, Aghamaali M, Najafi S, Hosseini SS, Amini M, Doustvandi MA, Mozammel N, Baradaran B, Mokhtarzadeh AA (2025) Microrna-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustine. Naunyn Schmiedebergs Arch Pharmacol 398(1):533\u2013542. https:\/\/doi.org\/10.1007\/s00210-024-03287-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"4562_CR116","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1208\/s12248-015-9757-1","volume":"17","author":"YK Zhang","year":"2015","unstructured":"Zhang YK, Wang YJ, Gupta P, Chen ZS (2015) Multidrug resistance proteins (MRPs) and cancer therapy. AAPS J 17(4):802\u2013812. https:\/\/doi.org\/10.1208\/s12248-015-9757-1","journal-title":"AAPS J"},{"issue":"4","key":"4562_CR117","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.3892\/mmr.2018.9375","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yao L, Yang J, Wang Z, Du G (2018) PI3K\/Akt and HIF-1 signaling pathway in hypoxia-ischemia (review). Mol Med Rep 18(4):3547\u20133554. https:\/\/doi.org\/10.3892\/mmr.2018.9375","journal-title":"Mol Med Rep"},{"issue":"1","key":"4562_CR118","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-024-01558-1","volume":"17","author":"P Zhang","year":"2024","unstructured":"Zhang P, Yue L, Leng Q, Chang C, Gan C, Ye T, Cao D (2024) Targeting FGFR for cancer therapy. J Hematol Oncol 17(1):39. https:\/\/doi.org\/10.1186\/s13045-024-01558-1","journal-title":"J Hematol Oncol"},{"key":"4562_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.951864","volume":"12","author":"X Zhou","year":"2022","unstructured":"Zhou X, Ao X, Jia Z, Li Y, Kuang S, Du C, Zhang J, Wang J, Liu Y (2022) Non-coding RNA in cancer drug resistance: underlying mechanisms and clinical applications. Front Oncol 12:951864. https:\/\/doi.org\/10.3389\/fonc.2022.951864","journal-title":"Front Oncol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04562-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04562-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04562-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:02:32Z","timestamp":1772049752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04562-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4562"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04562-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable since original data from humans or animals have not been used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}